艾弗梅克丁对COVID-19结果的影响:系统性审查和元分析
Nithin Sai Yengu1, Abdul Raheem2, Andrea Gómez Pons3
1Dr Pinnamaneni Siddhartha Institute of Medical Sciences, Vijayawada, India.
Annals of medicine and surgery (2012)
|March 20, 2025
概括
艾弗梅克丁对COVID-19患者的关键结果没有显著影响,包括死亡率或住院治疗. 然而,它确实加速了症状缓解,并提供了持续的症状缓解,与对照组相比,副作用的发生率相似.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 由于COVID-19的流行病造成了数百万人的死亡,需要有效的治疗方法.
- 一种重新设计的药物 - - 伊弗梅克 (Ivermectin) 显示出潜在的抗病毒特性,但其有效性和安全性的证据是相互矛盾的.
研究的目的:
- 在COVID-19患者中系统地审查和元分析ivermectin的疗效和安全性.
- 评估ivermectin对关键临床结果和症状缓解的影响.
主要方法:
- 按照MOOSE和PRISMA指南进行系统审查和元分析.
- 在Scopus,Embase,PubMed和Web of Science进行的搜索截至2024年4月.
- 分析了33项研究的数据,其中包括15376名参与者,使用综合元分析V3.
主要成果:
- 伊弗梅克丁对死亡率,机械通风,PCR转换,ICU入院或住院率没有显著影响.
- 观察到显著减少症状缓解和持续缓解症状的时间.
- 在ivermectin和对照组之间,不良事件的发生率是可比的;老年和糖尿病预测了AE.
结论:
- 伊弗梅克不会显著改变COVID-19患者的临床临床结果.
- 该药物在症状管理方面显示出好处,包括更快的缓解和持续的缓解.
- 进一步进行高质量的研究对于开发有效的COVID-19治疗和为公共卫生政策提供信息至关重要.
更多相关视频
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
967
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
12.6K
相关概念视频
01:14Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:30Electroconvulsive Therapy
21
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
21